Form 4 Tracker
David Malcom Rodman

Chief Medical Officer · 19 filings · Latest: Aug 10, 2026

Mineralys Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
MLYS
David Malcom RodmanChief Medical OfficerJan 20, 2026
Sale
$32.10416$13.4K50,437
MLYS
David Malcom RodmanChief Medical OfficerJan 20, 2026
Option Exercise
$15.44416$6.4K50,853
MLYS
Rodman David Malcom—Jan 20, 2026
Proposed Sale
$32.10416$13.4K—
MLYS
Rodman David Malcom—Jan 14, 2026
Proposed Sale
$32.6111,367$370.6K—
MLYS
Rodman David Malcom—Jan 13, 2026
Proposed Sale
$32.757,709$252.5K—
MLYS
Rodman David Malcom—Jan 12, 2026
Proposed Sale
$32.326,348$205.1K—
MLYS
Rodman David Malcom—Jan 9, 2026
Proposed Sale
$33.272,170$72.2K—
MLYS
Rodman David Malcom—Jan 2, 2026
Proposed Sale
$35.71262,752$9.4M—
MLYS
Rodman David Malcom—Oct 15, 2025
Proposed Sale
$43.0110,369$446.0K—
MLYS
Rodman David Malcom—Sep 15, 2025
Proposed Sale
$36.0011,367$409.3K—
MLYS
Rodman David Malcom—Aug 13, 2025
Proposed Sale
$12.9311,365$147.0K—
MLYS
Rodman David Malcom—Jul 14, 2025
Proposed Sale
$14.5911,366$165.9K—
MLYS
Rodman David Malcom—Jun 13, 2025
Proposed Sale
$14.6011,366$165.9K—
MLYS
Rodman David Malcom—May 14, 2025
Proposed Sale
$15.2911,366$173.8K—
MLYS
Rodman David Malcom—Apr 14, 2025
Proposed Sale
$14.5311,366$165.2K—
MLYS
Rodman David Malcom—Apr 1, 2025
Proposed Sale
$15.7655,771$879.0K—
MLYS
Rodman David Malcom—Nov 6, 2024
Proposed Sale
$15.0325,482$383.1K—
MLYS
Rodman David Malcom—Nov 11, 2024
Proposed Sale
$15.005,026$75.4K—

← Previous

Page 5 of 5